Bluepharma
Bluepharma is a Portuguese pharmaceutical group with over 50 years of experience, dedicated to innovation, research, development, manufacturing, and commercialization of medicines. It operates internationally with a focus on quality, sustainability, and strategic partnerships, aiming to provide high-value medicines and health products across various therapeutic areas.
Industries
Nr. of Employees
large (251-1000)
Patents
Products
Buccal spray delivery platform
Platform for buccal spray formulations enabling mucosal delivery of active substances.
Oral thin film platform
Thin-film dosage forms for rapid or controlled delivery via the oral mucosa.
Unit-dose sachet packaging (unitary dose)
Single-dose sachet packaging solution for powders or liquid formulations.
Lipid nanoparticle formulation platform
Platform for developing lipid-based nanosystems for complex injectable applications.
Polymer-based microparticle LAI platform
Microparticle formulations for long-acting injectable products.
Multilayer tablet technology
Multilayer tablet manufacturing capability to enable combined-release profiles and multi-active presentations.
Buccal spray delivery platform
Platform for buccal spray formulations enabling mucosal delivery of active substances.
Oral thin film platform
Thin-film dosage forms for rapid or controlled delivery via the oral mucosa.
Unit-dose sachet packaging (unitary dose)
Single-dose sachet packaging solution for powders or liquid formulations.
Lipid nanoparticle formulation platform
Platform for developing lipid-based nanosystems for complex injectable applications.
Polymer-based microparticle LAI platform
Microparticle formulations for long-acting injectable products.
Multilayer tablet technology
Multilayer tablet manufacturing capability to enable combined-release profiles and multi-active presentations.
Services
End-to-end development, scale-up, tech transfer and commercial manufacturing for pharmaceutical products.
Transfer of formulations from R&D into validated manufacturing processes and support for scale-up activities.
Identification of critical material attributes and process parameters and implementation of characterization methods for nanosystems and injectables.
Implementation and maintenance of GMP systems, ISO and environmental standards and support for regulatory inspections.
Support for market entry, international distribution and commercialization of medicinal and health products.
Organization-wide lean program to eliminate waste, standardize processes and increase operational resilience.
End-to-end development, scale-up, tech transfer and commercial manufacturing for pharmaceutical products.
Transfer of formulations from R&D into validated manufacturing processes and support for scale-up activities.
Identification of critical material attributes and process parameters and implementation of characterization methods for nanosystems and injectables.
Implementation and maintenance of GMP systems, ISO and environmental standards and support for regulatory inspections.
Support for market entry, international distribution and commercialization of medicinal and health products.
Organization-wide lean program to eliminate waste, standardize processes and increase operational resilience.
Expertise Areas
- Contract development and manufacturing (CDMO)
- Oral dosage form development and scale-up
- Complex injectable formulation and LNP development
- High-potency (oncology) manufacturing
Key Technologies
- Hot melt extrusion
- Lipid nanoparticle (LNP) systems
- Polymer-based microparticles (LAI)
- Oral thin films
News & Updates
An award event recognizing innovative research in health sciences, with winners presenting at European conferences.
Celebration of a decade of Bluepharma's operations in Mozambique, highlighting its growth and market presence.
A scientific publication discussing the application of Quality by Design in lipid nanosystems development.
Discussion on challenges and solutions in improving access to medicines.
Bluepharma has been recognized for its timely payments to suppliers for three consecutive years.
Celebration of the Bluelean continuous improvement program, emphasizing resilience and performance enhancement.
An award event recognizing innovative research in health sciences, with winners presenting at European conferences.
Celebration of a decade of Bluepharma's operations in Mozambique, highlighting its growth and market presence.
A scientific publication discussing the application of Quality by Design in lipid nanosystems development.
Discussion on challenges and solutions in improving access to medicines.
Bluepharma has been recognized for its timely payments to suppliers for three consecutive years.
Celebration of the Bluelean continuous improvement program, emphasizing resilience and performance enhancement.